FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009357282> ?p ?o ?g. }

• W2009357282 endingPage "2566" @default.
• W2009357282 startingPage "2557" @default.
• W2009357282 abstract "Objective: This pilot, uncontrolled, open-label study evaluated the safety/tolerability and potential effectiveness of OROS-methylphenidate (OROS-MPH) in adult attention deficit hyperactivity disorder (ADHD).Methods: Adults with DSM-IV-defined ADHD were enrolled in this 38-day study. Retrospective childhood diagnosis was made using the Wender Utah Rating Scale. Eligible patients required a baseline Conners Adult ADHD Rating Scale (CAARS) score ≥24, Clinical Global Impression of Severity (CGI-S) score ≥4 (at least moderate illness), and Montgomery–Asberg Depression Rating Scale (MADRS) score ≤ 16. Safety/tolerability measurements included adverse event reporting, vital signs, electrocardiograms (ECGs), weight, physical examination. Primary effectiveness evaluated changes in CAARS scores. Secondary effectiveness parameters included executive function.Results: Thirty-two patients formed the safety analysis; however, 30 comprised the effectiveness analysis since two patients did not meet diagnostic inclusion criteria. No serious adverse events were reported and there were no early withdrawals due to adverse events. There were no clinically significant changes in endpoint ECGs, physical examination, or blood pressure. Mean pulse rate increased by 5.9 beats/min (p = 0.003) and mean body weight decreased by 2.2 kg at endpoint (p < 0.0001). Total CAARS scores decreased significantly at endpoint as well as the inattention (p < 0.0001) and hyperactivity/ impulsivity symptom subscales (p < 0.0001) separately. Statistically significant improvements were observed in executive function and all other secondary measures, including the CAARS self report, CGI-S/CGI-I, Subject Satisfaction with treatment and the Sheehan Disability Scale (SDS). Mean dose of OROS-MPH = 52.3 ± 14.0 mg. Modal dose = 54 mg. Study limitations include: the lack of placebo control in the study design leading to potential observer bias, the exclusion of adults with unstable psychiatric and other medical conditions which is less reflective of clinical practice, and the short study duration.Conclusions: This uncontrolled, open-label trial suggests that OROS-MPH is well tolerated, providing core symptom control with the added benefit of improving executive function. However, future larger, randomized, controlled trials are required." @default.
• W2009357282 created "2016-06-24" @default.
• W2009357282 creator A5001142180 @default.
• W2009357282 creator A5032474292 @default.
• W2009357282 creator A5059872775 @default.
• W2009357282 creator A5071368511 @default.
• W2009357282 date "2006-11-30" @default.
• W2009357282 modified "2023-10-10" @default.
• W2009357282 title "Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder" @default.
• W2009357282 cites W1533684400 @default.
• W2009357282 cites W1967986347 @default.
• W2009357282 cites W1972555665 @default.
• W2009357282 cites W1987259395 @default.
• W2009357282 cites W1988567169 @default.
• W2009357282 cites W1994874108 @default.
• W2009357282 cites W2020470768 @default.
• W2009357282 cites W2047554178 @default.
• W2009357282 cites W2053924394 @default.
• W2009357282 cites W2058391602 @default.
• W2009357282 cites W2082008219 @default.
• W2009357282 cites W2095020785 @default.
• W2009357282 cites W2097626713 @default.
• W2009357282 cites W2106131177 @default.
• W2009357282 cites W2124264649 @default.
• W2009357282 cites W2131823335 @default.
• W2009357282 cites W2144579914 @default.
• W2009357282 cites W2154077719 @default.
• W2009357282 cites W2155595120 @default.
• W2009357282 cites W2160975086 @default.
• W2009357282 cites W2164676183 @default.
• W2009357282 cites W2405507916 @default.
• W2009357282 cites W2914151665 @default.
• W2009357282 cites W4236486344 @default.
• W2009357282 cites W4292856464 @default.
• W2009357282 doi "https://doi.org/10.1185/030079906x154132" @default.
• W2009357282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17166338" @default.
• W2009357282 hasPublicationYear "2006" @default.
• W2009357282 type Work @default.
• W2009357282 sameAs 2009357282 @default.
• W2009357282 citedByCount "40" @default.
• W2009357282 countsByYear W20093572822012 @default.
• W2009357282 countsByYear W20093572822014 @default.
• W2009357282 countsByYear W20093572822015 @default.
• W2009357282 countsByYear W20093572822016 @default.
• W2009357282 countsByYear W20093572822017 @default.
• W2009357282 countsByYear W20093572822018 @default.
• W2009357282 countsByYear W20093572822020 @default.
• W2009357282 countsByYear W20093572822022 @default.
• W2009357282 crossrefType "journal-article" @default.
• W2009357282 hasAuthorship W2009357282A5001142180 @default.
• W2009357282 hasAuthorship W2009357282A5032474292 @default.
• W2009357282 hasAuthorship W2009357282A5059872775 @default.
• W2009357282 hasAuthorship W2009357282A5071368511 @default.
• W2009357282 hasConcept C118552586 @default.
• W2009357282 hasConcept C126322002 @default.
• W2009357282 hasConcept C138496976 @default.
• W2009357282 hasConcept C142724271 @default.
• W2009357282 hasConcept C15744967 @default.
• W2009357282 hasConcept C168563851 @default.
• W2009357282 hasConcept C1862650 @default.
• W2009357282 hasConcept C187212893 @default.
• W2009357282 hasConcept C197934379 @default.
• W2009357282 hasConcept C203092338 @default.
• W2009357282 hasConcept C204787440 @default.
• W2009357282 hasConcept C27081682 @default.
• W2009357282 hasConcept C2776000289 @default.
• W2009357282 hasConcept C2777112843 @default.
• W2009357282 hasConcept C2778375690 @default.
• W2009357282 hasConcept C2780319597 @default.
• W2009357282 hasConcept C2780783007 @default.
• W2009357282 hasConcept C71924100 @default.
• W2009357282 hasConcept C83849319 @default.
• W2009357282 hasConceptScore W2009357282C118552586 @default.
• W2009357282 hasConceptScore W2009357282C126322002 @default.
• W2009357282 hasConceptScore W2009357282C138496976 @default.
• W2009357282 hasConceptScore W2009357282C142724271 @default.
• W2009357282 hasConceptScore W2009357282C15744967 @default.
• W2009357282 hasConceptScore W2009357282C168563851 @default.
• W2009357282 hasConceptScore W2009357282C1862650 @default.
• W2009357282 hasConceptScore W2009357282C187212893 @default.
• W2009357282 hasConceptScore W2009357282C197934379 @default.
• W2009357282 hasConceptScore W2009357282C203092338 @default.
• W2009357282 hasConceptScore W2009357282C204787440 @default.
• W2009357282 hasConceptScore W2009357282C27081682 @default.
• W2009357282 hasConceptScore W2009357282C2776000289 @default.
• W2009357282 hasConceptScore W2009357282C2777112843 @default.
• W2009357282 hasConceptScore W2009357282C2778375690 @default.
• W2009357282 hasConceptScore W2009357282C2780319597 @default.
• W2009357282 hasConceptScore W2009357282C2780783007 @default.
• W2009357282 hasConceptScore W2009357282C71924100 @default.
• W2009357282 hasConceptScore W2009357282C83849319 @default.
• W2009357282 hasIssue "12" @default.
• W2009357282 hasLocation W20093572821 @default.
• W2009357282 hasLocation W20093572822 @default.
• W2009357282 hasOpenAccess W2009357282 @default.
• W2009357282 hasPrimaryLocation W20093572821 @default.
• W2009357282 hasRelatedWork W1981980657 @default.
• W2009357282 hasRelatedWork W2009357282 @default.

• next